Literature DB >> 29944390

Oxytocin response to controlled dietary sodium and angiotensin II among healthy individuals.

Suman Srinivasa1,2, Anna Aulinas1, Timothy O'Malley2, Patrick Maehler2, Gail K Adler3, Steven K Grinspoon1,2, Elizabeth A Lawson1.   

Abstract

Oxytocin, while classically known for its role in parturition, lactation, and social behavior, also has been implicated in the control of sodium homeostasis in animal models. To improve our understanding of oxytocin physiology in humans, we measured basal oxytocin levels under low- and liberal-dietary-sodium conditions and following a peripheral angiotensin II (ANG II) infusion. Ten healthy individuals underwent a 6-day standardized low-sodium diet and a 6-day liberal-sodium diet. Each diet was followed by a graded ANG II infusion for 30-min sequential intervals at doses of 0.3, 1.0, and 3.0 ng·kg-1·min-1. Fasting serum oxytocin was assessed before and after ANG II infusion. Basal oxytocin levels (1,498.5 ± 94.7 vs. 1,663.3 ± 213.9 pg/ml, P = 0.51) did not differ after the low- and liberal-sodium diets. Following the ANG II infusion, ANG II levels and mean arterial pressure significantly increased as expected. In contrast, the ANG II infusion significantly lowered oxytocin levels from 1,498.5 ± 94.7 vs. 1,151.7 ± 118.1 pg/ml ( P < 0.001) on the low-sodium diet and from 1,663.3 ± 213.9 vs. 1,095.2 ± 87.4 pg/ml ( P = 0.03) on the liberal-sodium diet. The percent change in oxytocin following the ANG II infusion did not differ by sodium diet (-25 ± 5% vs. -28 ± 7% low- vs. liberal-sodium conditions, P > 0.99). Dietary sodium intake did not affect circulating oxytocin levels among healthy individuals. Systemic oxytocin levels were significantly suppressed following a peripheral ANG II infusion independent of dietary sodium conditions.

Entities:  

Keywords:  angiotensin II; dietary sodium; oxytocin

Mesh:

Substances:

Year:  2018        PMID: 29944390      PMCID: PMC6230706          DOI: 10.1152/ajpendo.00190.2018

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  29 in total

1.  Osmoregulatory control of renal sodium excretion after sodium loading in humans.

Authors:  L J Andersen; P Norsk; L B Johansen; P Christensen; T Engstrom; P Bie
Journal:  Am J Physiol       Date:  1998-12

2.  The effects of prolonged administration of vasopressin and oxytocin on renin, aldosterone and sodium balance in normal man.

Authors:  F J Goodwin; J G Ledingham; J H Laragh
Journal:  Clin Sci       Date:  1970-11       Impact factor: 6.124

3.  Effect of central hypertonic stimulation on plasma atrial natriuretic peptide and oxytocin in conscious rats.

Authors:  T Hattori; G M So; M Morris; P M Hutchins; D K Sundberg
Journal:  Regul Pept       Date:  1988-12

Review 4.  The circumventricular organs and the central actions of angiotensin.

Authors:  J B Simpson
Journal:  Neuroendocrinology       Date:  1981-04       Impact factor: 4.914

5.  RAAS Activation Is Associated With Visceral Adiposity and Insulin Resistance Among HIV-infected Patients.

Authors:  Suman Srinivasa; Kathleen V Fitch; Kimberly Wong; Martin Torriani; Caitlin Mayhew; Takara Stanley; Janet Lo; Gail K Adler; Steven K Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2015-06-18       Impact factor: 5.958

6.  Arginine vasopressin and oxytocin responses to angiotensin II are mediated by AT1 receptor subtype in normal men.

Authors:  P Chiodera; R Volpi; A Caiazza; N Giuliani; M G Magotti; V Coiro
Journal:  Metabolism       Date:  1998-08       Impact factor: 8.694

7.  Systemic osmotic stimulation increases vasopressin and oxytocin release within the supraoptic nucleus.

Authors:  M Ludwig; M F Callahan; I Neumann; R Landgraf; M Morris
Journal:  J Neuroendocrinol       Date:  1994-08       Impact factor: 3.627

8.  Glucocorticoid modulation of atrial natriuretic peptide, oxytocin, vasopressin and Fos expression in response to osmotic, angiotensinergic and cholinergic stimulation.

Authors:  F Lauand; S G Ruginsk; H L P Rodrigues; W L Reis; M de Castro; L L K Elias; J Antunes-Rodrigues
Journal:  Neuroscience       Date:  2007-05-23       Impact factor: 3.590

9.  Melatonin inhibits oxytocin response to insulin-induced hypoglycemia, but not to angiotensin II in normal men.

Authors:  P Chiodera; R Volpi; L Capretti; N Giuliani; G Caffarri; V Coiro
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

10.  Low dietary sodium and exogenous angiotensin II infusion decrease plasma adiponectin concentrations in healthy men.

Authors:  A Titia Lely; Jan A Krikken; Stephan J L Bakker; Frans Boomsma; Robin P F Dullaart; Bruce H R Wolffenbuttel; Gerjan Navis
Journal:  J Clin Endocrinol Metab       Date:  2007-03-06       Impact factor: 5.958

View more
  2 in total

Review 1.  Potential of Endogenous Oxytocin in Endocrine Treatment and Prevention of COVID-19.

Authors:  Stephani C Wang; Fengmin Zhang; Hui Zhu; Haipeng Yang; Yang Liu; Ping Wang; Vladimir Parpura; Yu-Feng Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-03       Impact factor: 6.055

Review 2.  Cardiovascular protective properties of oxytocin against COVID-19.

Authors:  Stephani C Wang; Yu-Feng Wang
Journal:  Life Sci       Date:  2021-01-26       Impact factor: 6.780

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.